Arecor granted European patents to protect Humira formulations
Patents show potential of innovative Arestat technology and the development of enhanced formulations
Read More
Tag: Humira
EU authorises Celltrion’s adalimumab biosimilar Yuflyma
Yuflyma is approved across 13 indications for the treatment of multiple chronic inflammatory diseases
Read More
Rinvoq NICE approval could benefit 54,000 people
Rinvoq has already been available in the US since last August, and in Europe since December.
Read More
Entyvio beats Humira in head-to-head ulcerative colitis trial
Results offer new insight to support treatment decisions, Takeda says
Read More
NHS saves more than £700m on medicines costs
A huge part of the saving was made up by AbbVie’s Humira losing its patent.
Read More
AbbVie to buy Allergan in $63b mega-merger
The deal is the second huge merger this year, after January’s Bristol-Myers Squibb & Celgene deal.
Read More
Positive late stage rheumatoid arthritis trial results for Abbvie
Upadacitinib was found to have achieved both primary endpoints with significantly higher rates of ACR20 response and low disease activity at week 14.
Read More
Takeda’s Entyvio bests AbbVie’s Humira in ulcerative colitis trial
Takeda’s Entyvio has beaten AbbVie’s Humira on achieving clinical remission in patients with ulcerative colitis, in the first trial to directly compare the efficacy and safety of two commonly used biologics for the disease.
Read More
NICE approves Xeljanz for Ulcerative Colitis
The National Institute for Health and Care Excellence (NICE) has approved Pfizer’s Xeljanz for adults with moderate to severe active ulcerative colitis.
Read More
NHS set to save record £300 million on highest drug spend
The NHS is set to save a record £300 million after negotiating deals with five manufacturers on low-cost versions of the health service’s most costly drug.
Read More
Another Humira biosimilar hits EU shores
Samsung Bioepis has announced the European launch of Humira biosimilar Imraldi, as NHS chiefs tell Trusts to ensure they are ready to realise the potential savings from using cheaper versions of the world’s biggest selling drug.
Read More
Amgen begins rolling out Humira biosimilar in the EU
Amgen has begun launching Amgevita, the first biosimilar of AbbVie’s anti-inflammatory blockbuster Humira to win approval in Europe, across the region.
Read More
- UKHSA and ICL confirm variant which plays key role in global surge of Strep A infections
- Study reveals heart failure device could monitor patients and prevent hospitalisation
- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
